Benjamin Brady
Peter MacCallum Cancer Centre · 24 works · 7,129 citations · h-index 14
Top works
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
- Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
- Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
- Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma
- Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series
- Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
- Optimizing combination dabrafenib and trametinib therapy in BRAF mutation‐positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
- Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma
- Nevi and Melanoma: Lessons from Turner’s Syndrome
- Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
- A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy
- The Genes and Genetics of Malignant Melanoma
- Melanoma and immunotherapy bridge 2015
- Integration of Immuno-Oncology and Palliative Care
- The effect of flavopiridol on the growth of p16+ and p16− melanoma cell lines
- Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma.
- Cerebrovascular disease in type 1A glycogen storage disease
- Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group
- Complete Remission of Metastatic Melanoma with Nivolumab and Complete Remission of Hepatitis C with Ledipasvir